MARC MCCOLLAUM: Open Payments
NPI 1871545046 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,315 in 23 payments from 8 companies in 2025. Trend: 2023 $924 · 2024 $679 · 2025 $1,315
Food & beverage: $1,315
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 6 | $639 |
| Lilly USA, LLC | 4 | $182 |
| Neurocrine BioSciences, Inc. | 1 | $136 |
| Corcept Therapeutics | 1 | $125 |
| Tandem Diabetes Care, Inc. | 4 | $109 |
| AstraZeneca Pharmaceuticals LP | 5 | $92 |
| Medtronic, Inc. | 1 | $17 |
| Philips North America LLC | 1 | $15 |
Products named: REZDIFFRA, INGREZZA, ZEPBOUND, Korlym, t:slim X2 Insulin Pump with Control-IQ, MOUNJARO, FARXIGA, AIRSUPRA.
Industry payments across FL — which companies pay providers there.
